A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China

Acta Tropica

Volumn 106, Issue 3, 2008, Pages 190-194

  Wen, Li Yong ^a   Yan, Xiao Lan ^a   Sun, Feng Hua ^b   Fang, Yue Yi ^c   Yang, Ming Jin ^a   Lou, Lei Jun ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^c Guangdong Institute of Parasitic Diseases Control   (China)

Author keywords

Albendazole; China; Double blind trial; Intestinal nematodes; Ivermectin

Indexed keywords

ALBENDAZOLE; IVERMECTIN; PLACEBO;

DISEASE TREATMENT; DOSE-RESPONSE RELATIONSHIP; IVERMECTIN; NEMATODE; PERFORMANCE ASSESSMENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; ASCARIS LUMBRICOIDES; CHILD; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROBIUS VERMICULARIS; FATIGUE; FECES; FEMALE; HOOKWORM; HUMAN; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEMATODE; NEMATODIASIS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TRICHURIS; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ALBENDAZOLE; ANIMALS; ANTINEMATODAL AGENTS; ASCARIASIS; ASCARIS LUMBRICOIDES; CHILD; CHINA; DOUBLE-BLIND METHOD; ENTEROBIASIS; ENTEROBIUS; FECES; FEMALE; HUMANS; INTESTINAL DISEASES, PARASITIC; IVERMECTIN; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRICHURIASIS; TRICHURIS;

ASIA; CHINA; EURASIA; FAR EAST;

ANCYLOSTOMATOIDEA; ASCARIS; ASCARIS LUMBRICOIDES; ENTEROBIUS; ENTEROBIUS VERMICULARIS; NEMATODA; TRICHURIS; TRICHURIS TRICHIURA;

EID: 43849101262     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.03.007     Document Type: Article

References (31)

1. Aziz M.A. Chemotherapeutic approach to control of onchocerciasis. Rev. Infect. Dis. 8 (1986) 500-504
2. Bogan J.A. Pharmacodynamic and toxicological aspects of albendazole in man and animals. In: Firth M. (Ed). Albendazole in Helminthiasis. Royal Society of Medicine International Congress and Symposium Series No. 61 (1984), Royal Society of Medicine 13
3. Campbell W.C., Fisher M.H., Stapley E.O., Albers-Schonberg G., and Jacob T.A. Ivermectin: a potent new antiparasitic agent. Science 221 (1983) 823-828
4. Cappello M. Global health impact of soil-transmitted nematodes. Pediatr. Infect. Dis. J. 23 (2004) 663-674
5. Collins K. Profitable gifts: a history of the Merck Mectizan donation program and its implications for international health. Perspect. Biol. Med. 47 (2004) 100-109
6. De Clerq D., Sacko M., Behnke J., Gilbert F., Dorny P., and Vercruysse J. Failure of mebendazole in treatment of human hookworm infections in the Southern Region of Mali. Am. J. Trop. Med. Hgy. 57 (1997) 25-30
7. Freedman D.O., Zierdt W.S., Lujan A., and Nutman T.B. The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans. J. Infect. Dis. 159 (1989) 1151-1153
8. Frohberg H. The toxicological profile of praziquantel in comparison to other anthelminthic drugs. Acta Leiden. 57 (1989) 201-215
9. Horten J. Human gastrointestinal helminth infections: are they now neglected diseases?. Trends Parasitol. 19 (2003) 527-531
10. Kane N.S., Hirschberg B., and Qian S. Drug-resistant Drosophilia indicate glutamate-gated chloride channels are targets for the antiparasitics nodulispordic acid and ivermectin. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13949-13954
11. Katz Z., Chaves A., and Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paulo 14 (1972) 397-400
12. Liu Y.H., Wang X.G., Gao P., and Qian M.X. Experimental and clinical trial of albendazole in the treatment of clornorchiasis sinensis. Chin. Med. J. 104 (1991) 27-32
13. Lo P.K., Fink D.W., Williams J.B., and Blodinger J. Pharmacokinetic studies of ivermectin: effects of formulation. Vet. Res. Commun. 9 (1985) 251-268
14. Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., and Hatz C. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg. 55 (1996) 477-481
15. Mascie-Taylor C.G., and Karim E. The burden of chronic disease. Science 12 (2003) 1921-1922
16. Naquira C., Jimenez G., Guerra J.G., Bernal R., Nalin D.R., Neu D., and Aziz M. Ivermectin for human strongyloidiasis and other intestinal helminths. Am. J. Trop. Med. Hyg. 40 (1989) 304-309
17. Out-Bassey I.B., Ejezje G.C., Epoke J., and Useh M.F. Enterobiasis and its relationship with anal itching and enuresis among school-age children in Calabar, Nigeria. Ann. Trop. Med. Parasitol. 99 (2005) 611-616
18. Ranque S., Chippaus J.P., Garcia A., and Boussinesq M. Follow-up of Ascaris lumbricoides and Trichuris trichiura infections in children living in a community treated with ivermectin at 3-monthly intervals. Ann. Trop. Med. Parasitol. 95 (2001) 389-393
19. Ros-Moreno R.M., Moreno-Guzman M.J., Jimenez-Gonzalez A., and Rodriguez-Caabeiro F. Interaction of ivermectin with gamma-aminobutyric acid receptors in Trichinella spiralis muscle larvae. Parasitol. Res. 85 (1999) 320-323
20. Savioli L., Standfield S., Bundy D.A.P., Mitchell A., Bhatia R., Engels D., Montresor A., Neira M., and Shein A.M. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 577-579
21. Shan Q., Haddrill J.L., and Lynch J.W. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J. Biol. Chem. 276 (2001) 12556-12564
22. Speare R., and Durrheim D. Mass treatment with ivermectin: an underutilized public health strategy. Bull. World Health Org. 82 (2004) 562-564
23. TDR/GEN/07.1, 2007. Eighteenth Programme Report-Progress, 2005-2006. Geneva, pp. 36-37.
24. Urbani C., and Albonico M. Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns. Acta Trop. 86 (2003) 215-221
25. Utzinger J., and Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 5 (2004) 263-285
26. Wen L.Y., and Song C.C. Toxic effects of levamisole-review. Chin. J. Parasotol. Parasitic Dis. 18 (2000) 186-187 (in Chinese)
27. Wen L.Y., Xia Z.H., Yao S.Y., and Ren S.P. Experimental study on ivermectin for treatment of Ancylostoma caninum, Nippostrongylus brasiliensis and syphacia mesocriceti. Chin. J. Zoonoses 15 (1999) 27-29 (in Chinese)
28. WHO Expert Committee, 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ. Tech. Rep. Ser. 912. Geneva, pp. 1-57, and back cover
29. World Health Organization. Drugs Used in Parasitic Diseases. second ed. (1995), WHO, Geneva
30. Xia Z.H., Su Y.L., Yao S.Y., Shen B.R., Wen L.Y., Song C.C., Wu Z.K., Zhou Y.C., Meng J.C., and Yang H.L. Clinical observation on anthelmintic treatment of intestinal nematode infection with ivermectin. Chin. J. Parasitol. Parasitic Dis. 10 (1992) 279-281 (in Chinese)
31. Zheng R.Y., Jiang Z.C., and Zhang X. Relationship between levamisole and encephalitis syndrome. Chin. J. Intern. Med. 31 (1992) 530-532 (in Chinese)